A majority of youths who report having used tobacco say their first experience using tobacco involved a flavored product. That’s the key finding of new research based on the first large U.S.

Roswell Park Comprehensive Cancer Center received more than $7.2 million in grant awards for important research projects during the third quarter of 2015.

The key to immune-based cancer therapies lies in the ability to exploit some weakness within the tumor and its environment or to elude cancer’s offenses. Researchers led by a group from the Roswell Park Cancer Institute Center for Immunotherapy have shared new insights about a subset of T cells that appear to do both those things.